earnings

NASDAQ · LXRX
Lexicon Pharmaceuticals, Inc.
Healthcare · Biotechnology
$1.44
Up+$0.02 (+1.39%)
Updated Nov 3, 2026, 5:43 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 481.5M
- P/E ratio
- -3.99
- Dividend yield
- 0.00%
- 52-week range
- $1.37 – $2.68
- Volume
- 2.02M
- Avg. volume
- 2.31M
Price performance · LXRX
LXRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
LXRX closed at $1.44 after 21 trading sessions, down 17.24% for the selected period.
- Last close
- $1.44
- Period change
- -17.24%
- Period low
- $1.42
- Period high
- $1.76
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $1.44 | $1.45 | $1.40 | $1.44 | 2.02M |
| Oct 30, 2026 | $1.47 | $1.4961 | $1.375 | $1.42 | 2.44M |
| Oct 29, 2026 | $1.50 | $1.52 | $1.43 | $1.48 | 1.77M |
| Oct 28, 2026 | $1.47 | $1.49 | $1.43 | $1.485 | 1.62M |
| Oct 27, 2026 | $1.47 | $1.49 | $1.435 | $1.48 | 1.86M |
| Oct 26, 2026 | $1.40 | $1.48 | $1.40 | $1.45 | 2.21M |
| Oct 23, 2026 | $1.50 | $1.50 | $1.365 | $1.42 | 2.68M |
| Oct 22, 2026 | $1.56 | $1.59 | $1.48 | $1.49 | 1.32M |
| Oct 21, 2026 | $1.59 | $1.6171 | $1.545 | $1.56 | 1.4M |
| Oct 20, 2026 | $1.56 | $1.63 | $1.545 | $1.58 | 1.41M |
| Oct 19, 2026 | $1.55 | $1.5799 | $1.5102 | $1.55 | 1.72M |
| Oct 16, 2026 | $1.68 | $1.68 | $1.52 | $1.52 | 2.01M |
| Oct 15, 2026 | $1.63 | $1.675 | $1.62 | $1.65 | 1.43M |
| Oct 14, 2026 | $1.61 | $1.63 | $1.56 | $1.60 | 1.91M |
| Oct 13, 2026 | $1.65 | $1.655 | $1.59 | $1.61 | 2.05M |
| Oct 12, 2026 | $1.65 | $1.67 | $1.605 | $1.65 | 2.03M |
| Oct 9, 2026 | $1.75 | $1.77 | $1.67 | $1.68 | 2.07M |
| Oct 8, 2026 | $1.75 | $1.78 | $1.695 | $1.76 | 3.32M |
| Oct 7, 2026 | $1.73 | $1.77 | $1.7137 | $1.76 | 1.1M |
| Oct 6, 2026 | $1.75 | $1.78 | $1.72 | $1.75 | 1.64M |
| Oct 5, 2026 | $1.83 | $1.83 | $1.72 | $1.74 | 2.72M |
Latest LXRX news
The latest Smart Investors Daily articles mentioning LXRX.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

